PDCD1 and melanoma: PD-1/PD-L1 axis is a major immune checkpoint important in the prognosis of several solid tumors (melanoma, hepatocellular carcinoma, and more recently HNSCC) (21–24) and is being clinically targeted for immunotherapy (25–29).